Sedana Medical AB: Sedana Medical reports first patient treated in Early Access Program in the U.S.

Sedana Medical AB (publ) today reports that the first patient has been treated in the company's Early Access Program (EAP) in the U.S. The program is approved by the U.S. Food and Drug Administration ...